Medicine


Harvard’s Wyss Institute Gives Startup License to Use Newly-Developed Biomaterials

Attivare Therapeutics, a startup founded by researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering, received a license from the Wyss Institute to use biomaterials developed at Harvard to create treatments for tumors that do not respond to existing immunotherapies.


Brigham and Women's Hospital Researchers Find Nasal Spray Protects Against Respiratory Illnesses

Researchers found that a drug-free nasal spray protected against airborne respiratory illnesses — including Covid-19, influenza, viruses, and pneumonia — in a preclinical study published by Harvard Medical School-affiliated Brigham and Women’s Hospital on Sept. 24.


Dana-Farber CEO Laurie Glimcher To Step Down, Succeeded By Medical Oncology Chair

Dana-Farber Cancer Institute President and CEO Laurie H. Glimcher ’72 will step down from her post at the end of September, the institute announced on Tuesday.


Judge to Rule on Transfer of St. Elizabeth’s Hospital to Boston Medical Center Amid Steward Crisis

A federal judge in Texas is set to decide whether to approve the sale of St. Elizabeth’s Medical Center in Brighton to Boston Medical Center in a Wednesday hearing following the bankruptcy of its owner, Steward Health Care.


Science Retracts Paper by Dana-Farber President Over Discrepancies in Multiple Figures

The journal Science retracted a 2006 paper by Dana-Farber Cancer Institute President and CEO Laurie H. Glimcher ’72 on Thursday due to discrepancies in several figures.


Mass General Researchers Report Major Breakthrough in Deadly Brain Cancer Treatment

Researchers at the Mass General Cancer Center reported a breakthrough in treatment for glioblastoma in a March 13 paper published in the New England Journal of Medicine.


Dana-Farber to Retract 6 Papers, Correct 31 Following Data Manipulation Claims

The Dana-Farber Cancer Institute initiated retractions or corrections to 37 papers authored by four senior researchers following allegations of data falsification, according to a DFCI research integrity officer Sunday.


Dana-Farber Cancer Institute Researchers Accused of Manipulating Data

Four senior researchers at the Dana-Farber Cancer Institute allegedly falsified data in multiple papers, a data investigation blogger claimed last Tuesday.


MGH Researchers Develop AI Tool To Predict Melanoma Recurrence

Scientists at Massachusetts General Hospital have developed a new tool that uses artificial intelligence to predict which patients are most likely to experience a recurrence of melanoma, the most deadly form of skin cancer.


Scripps Research Director Eric Topol Discusses Covid Vaccination and Misinformation at Belfer Center

Cardiologist Eric J. Topol, founder and director of the Scripps Research Translational Institute, discussed Covid-19 vaccination as part of the Harvard Kennedy School Belfer Center’s Diversity in STEM series on Wednesday in conversation with Belfer Fellow and epidemiologist Syra Madad.


1-25 of 240
Older ›
Oldest »